about
β1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastomaThe role of cancer stem cells and miRNAs in defining the complexities of brain metastasisImmunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastasesA review of current management of brain metastases.Role of the endothelin axis in astrocyte- and endothelial cell-mediated chemoprotection of cancer cells.Opposing effects of pigment epithelium-derived factor on breast cancer cell versus neuronal survival: implication for brain metastasis and metastasis-induced brain damage.Macrolide analog F806 suppresses esophageal squamous cell carcinoma (ESCC) by blocking β1 integrin activation.Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats.Combining temozolomide with other antitumor drugs and target-based agents in the treatment of brain metastases: an unending quest or chasing a chimera?Circulating biomarkers of CNS tumors: an update.Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC.The brain metastatic niche.Expression profiling of angiogenesis-related genes in brain metastases of lung cancer and melanoma.Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases.Tumor margin identification and prediction of the primary tumor from brain metastases using FTIR imaging and support vector machines.Maintaining unperturbed cerebral blood flow is key in the study of brain metastasis and its interactions with stress and inflammatory responses.Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastases.Characterization of the inflammatory response to solid cancer metastases in the human brain.Tumour-infiltrating lymphocytes and expression of programmed death ligand 1 (PD-L1) in melanoma brain metastases.
P2860
Q24564890-ABCF24B0-EAC0-4163-A507-2C941CF84FEEQ26864372-83CB9194-9770-47B7-8A43-D1D6373276BBQ28250795-47026488-50F2-4A3D-8691-2E987A422461Q34000987-B9B25A33-71F1-48B8-8F7C-059D52C729E0Q34511723-380CE394-AA4C-440C-81CE-EEF23813D9D5Q35662043-83E031B6-BC47-47B2-A39A-F2E63708E1DCQ36140675-E29D09E4-9308-4CD3-9849-2C10C24E622BQ37409716-AE07DEBB-19EE-497E-989F-72A7BFB2E5CBQ37870216-19981607-2CC6-4E19-B4EB-E3B863944D55Q38095109-95C838AB-702E-489C-9924-AD98CB3069A4Q38096437-C7D64ECC-ED6F-43C5-9E7F-13554C317349Q38613307-56C81D61-0B52-4307-8870-19E5981612FFQ40638741-EAA27BCA-5AF3-4CC2-95EA-8C1250580ACAQ45905781-2E3DFD2C-2CAB-4AA1-92B0-FA68EA149DECQ48093720-18F8275F-867C-4B21-97F9-41DAE5A830E0Q48300160-6A41549F-9B2C-4F96-BB93-C8C4340F60B8Q48401767-78DD6F53-1366-4184-BE25-53FD971A4920Q48453582-2073723D-0EED-4B20-BEE6-A3CE462179F5Q48485643-AAAE9F90-198E-42B4-9FF0-81BF88FF166C
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Therapy and prophylaxis of brain metastases.
@en
Therapy and prophylaxis of brain metastases.
@nl
type
label
Therapy and prophylaxis of brain metastases.
@en
Therapy and prophylaxis of brain metastases.
@nl
prefLabel
Therapy and prophylaxis of brain metastases.
@en
Therapy and prophylaxis of brain metastases.
@nl
P2860
P356
P1476
Therapy and prophylaxis of brain metastases.
@en
P2093
Frank Winkler
Yvonne Kienast
P2860
P304
P356
10.1586/ERA.10.165
P577
2010-11-01T00:00:00Z